These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3055921)

  • 21. Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study.
    Havel RJ; Hunninghake DB; Illingworth DR; Lees RS; Stein EA; Tobert JA; Bacon SR; Bolognese JA; Frost PH; Lamkin GE
    Ann Intern Med; 1987 Nov; 107(5):609-15. PubMed ID: 3662274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of simvastatin and lovastatin in patients with hypercholesterolemia. The Simvastatin and Lovastatin Multicenter Study Participants.
    Farmer JA; Washington LC; Jones PH; Shapiro DR; Gotto AM; Mantell G
    Clin Ther; 1992; 14(5):708-17. PubMed ID: 1468089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of clinical trials comparing HMG-CoA reductase inhibitors.
    Illingworth DR; Tobert JA
    Clin Ther; 1994; 16(3):366-85; discussion 365. PubMed ID: 7923304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lovastatin for hypercholesterolemia.
    Zeller FP; Uvodich KC
    Drug Intell Clin Pharm; 1988; 22(7-8):542-5. PubMed ID: 3046888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meeting national cholesterol education goals in clinical practice--a comparison of lovastatin and fluvastatin in primary prevention.
    Nash DT
    Am J Cardiol; 1996 Sep; 78(6A):26-31. PubMed ID: 8875972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of dyslipidemia in non-insulin-dependent diabetes mellitus with lovastatin.
    Garg A; Grundy SM
    Am J Cardiol; 1988 Nov; 62(15):44J-49J. PubMed ID: 3055923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia].
    Catalán M; López de Ocáriz A; Alvarez MP; Ariño M; Azanza JR; Honorato J
    Rev Med Univ Navarra; 1992; 37(3):127-33. PubMed ID: 1480917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simvastatin: the clinical profile.
    Walker JF
    Am J Med; 1989 Oct; 87(4A):44S-46S. PubMed ID: 2801750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: the Finnish Multicenter Study.
    Tikkanen MJ; Helve E; Jäättelä A; Kaarsalo E; Lehtonen A; Malbecq W; Oksa H; Pääkkönen P; Salmi J; Veharanta T
    Am J Cardiol; 1988 Nov; 62(15):35J-43J. PubMed ID: 3055922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia.
    Plosker GL; Wagstaff AJ
    Drugs; 1996 Mar; 51(3):433-59. PubMed ID: 8882381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.
    Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA
    Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of lovastatin in a six-month study: analysis by gender, age and hypertensive status.
    Kannel WB; D'Agostino RB; Stepanians M; D'Agostino LC
    Am J Cardiol; 1990 Sep; 66(8):1B-10B. PubMed ID: 2206030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia.
    Bradford RH; Shear CL; Chremos AN; Dujovne C; Franklin FA; Hesney M; Higgins J; Langendörfer A; Pool JL; Schnaper H
    Am J Cardiol; 1990 Sep; 66(8):44B-55B. PubMed ID: 2206036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lovastatin extended release: a review of its use in the management of hypercholesterolaemia.
    Curran MP; Goa KL
    Drugs; 2003; 63(7):685-99. PubMed ID: 12656649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
    Richter WO; Jacob BG; Schwandt P
    Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis].
    Giannini SD; de Góes JM; Dereviack BE; Machado C; Forti N; Diament J
    Arq Bras Cardiol; 1990 Jun; 54(6):407-14. PubMed ID: 2288531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies.
    Davignon J; Hanefeld M; Nakaya N; Hunninghake DB; Insull W; Ose L
    Am J Cardiol; 1998 Aug; 82(4B):32J-39J. PubMed ID: 9737644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin and the human lens. Clinical results of a 3-year follow-up.
    Behrens-Baumann W; Thiery J; Wieland E; Fieseler HG; Seidel D
    Arzneimittelforschung; 1992 Aug; 42(8):1023-4. PubMed ID: 1418074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.
    D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
    Am J Cardiol; 1992 Jan; 69(1):28-34. PubMed ID: 1729864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.